Similarly, the CD8+ T cell expression level is positively correlated with the cumulative survival of EC (Figure 1(k)), which suggested that KIF2C may be involved in remodeling the tumor immune environment and thereby promoting the malignant progression of EC. The gene discussed is KIF2C; the disease is neoplasm.